Literature DB >> 20706597

UNSUSPECTED FATAL DRUG-RESISTANT TUBERCULOSIS IN A CLOSELY MONITORED CHILD: A PLEA FOR IMPROVED SOURCE-CASE TRACING AND DRUG SUSCEPTIBILITY TESTING.

Steve Innes1, H Simon Schaaf, Kim Gp Hoek, Helena Rabie, Mf Cotton.   

Abstract

We report a case of rapidly progressive miliary tuberculosis in a 21-month old HIV-infected girl exposed to tuberculosis, despite early access to highly active antiretroviral therapy and proven adherence to isoniazid chemoprophylaxis. Post mortem revealed multidrug-resistant tuberculosis. This case report illustrates the consequences of inadequate programmatic management of children exposed to an adult case of sputum smear-positive multidrug-resistant tuberculosis. Drug susceptibility testing of the adult source case should become standard of care for all children who have been in close contact with a case of sputum smear-positive tuberculosis, and the choice of chemoprophylactic agents should be based on the sensitivities of the source case organism.

Entities:  

Year:  2010        PMID: 20706597      PMCID: PMC2919746     

Source DB:  PubMed          Journal:  South Afr J Epidemiol Infect        ISSN: 1015-8782


  10 in total

1.  How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control.

Authors:  Stephen D Lawn; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2005-07-22       Impact factor: 4.177

2.  Use of DNA extracts from Ziehl-Neelsen-stained slides for molecular detection of rifampin resistance and spoligotyping of Mycobacterium tuberculosis.

Authors:  A G M Van Der Zanden; E M Te Koppele-Vije; N Vijaya Bhanu; D Van Soolingen; L M Schouls
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

3.  Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up.

Authors:  H Simon Schaaf; Robert P Gie; Magdalene Kennedy; Nulda Beyers; Peter B Hesseling; Peter R Donald
Journal:  Pediatrics       Date:  2002-05       Impact factor: 7.124

4.  Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates.

Authors:  M Heep; B Brandstätter; U Rieger; N Lehn; E Richter; S Rüsch-Gerdes; S Niemann
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

5.  Culture confirmed multidrug resistant tuberculosis: diagnostic delay, clinical features, and outcome.

Authors:  H S Schaaf; K Shean; P R Donald
Journal:  Arch Dis Child       Date:  2003-12       Impact factor: 3.791

6.  Culture-positive tuberculosis in human immunodeficiency virus type 1-infected children.

Authors:  H S Schaaf; A Geldenduys; R P Gie; M F Cotton
Journal:  Pediatr Infect Dis J       Date:  1998-07       Impact factor: 2.129

7.  Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases.

Authors:  Darryl B Sneag; H Simon Schaaf; Mark F Cotton; Heather J Zar
Journal:  Pediatr Infect Dis J       Date:  2007-12       Impact factor: 2.129

8.  Early antiretroviral therapy and mortality among HIV-infected infants.

Authors:  Avy Violari; Mark F Cotton; Diana M Gibb; Abdel G Babiker; Jan Steyn; Shabir A Madhi; Patrick Jean-Philippe; James A McIntyre
Journal:  N Engl J Med       Date:  2008-11-20       Impact factor: 91.245

9.  Clinical presentation and outcome of tuberculosis in human immunodeficiency virus infected children on anti-retroviral therapy.

Authors:  Elisabetta Walters; Mark F Cotton; Helena Rabie; H Simon Schaaf; Lourens O Walters; Ben J Marais
Journal:  BMC Pediatr       Date:  2008-01-11       Impact factor: 2.125

10.  Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases.

Authors:  H Simon Schaaf; Ben J Marais; Andrew Whitelaw; Anneke C Hesseling; Brian Eley; Gregory D Hussey; Peter R Donald
Journal:  BMC Infect Dis       Date:  2007-11-29       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.